Sep 27, 2019 - AbbVie (ABBV) gets FDA approval for the label expansion of Mavyret.
Sep 27, 2019 - IntelGenx Corp. (IGXT) resubmits NDA for Rizaport VersaFilm for the treatment of acute migraines to the FDA.
Sep 26, 2019 - Sanofi's (SNY) stock is on an upward trajectory this year. Let us have a look at the reasons for the same.
Sep 26, 2019 - Tyme (TYME) initiates the pivotal stage of the TYME-88-Panc study evaluating oral SM-88 (racemetyrosine) for third-line treatment of patients with metastatic pancreatic cancer.
Sep 25, 2019 - Bristol-Myers (BMY) receives a positive response from the CHMP for a four-week dosing option with Opdivo as an adjuvant treatment of adult patients with melanoma.
Sep 25, 2019 - A fundamentally stable U.S. economy, which is growing for history setting 11 years, albeit at a slow pace and a dovish Fed in 2019 are the two major drivers of the Dow.
Sep 24, 2019 - Clovis (CLVS) enters into licensing and collaboration agreement with 3B Pharmaceuticals and acquires rights to FAP targeted radiopharmaceutical therapy for developing new cancer treatments.
Sep 23, 2019 - Glaxo's (GSK) SLE drug Benlysta gets a favorable CHMP opinion that recommends an approval for intravenous formulation in pediatric patients.
Sep 23, 2019 - Merck's (MRK) new HIV drugs, Pifeltro and Delstrigo, get FDA nod for use in treatment-experienced adults living with HIV-1 who are virologically suppressed.
Sep 23, 2019 - Pfizer (PFE)/Merck KGaA's label expansion application for Bavencio in combination with Inlyta gets positive CHMP recommendation for first-line treatment of advanced kidney cancer.